|
ViaCell, Inc. [VIAC] President & CEO presided over the closing bell.
|
| |
ViaCell, Inc. [VIAC] President & CEO presided over the closing bell.
|
ViaCell, Inc. [VIAC]
President & CEO
presided over
the closing bell.
Friday, January 21, 2005
at NASDAQ's MarketSite
in New York City.
ViaCell, Inc. |
| |
| NASDAQ is proud to welcome Marc D. Beer, CEO of ViaCell, Inc. to the closing bell in celebration of the company's listing on The NASDAQ Stock Market. ViaCell, Inc. will begin trading under the symbol [VIAC]. ViaCell is dedicated to enabling the widespread application of human cells as medicine in the treatment of human disease. |
| |
About ViaCell, Inc. [VIAC]:
ViaCell, Inc. is a clinical-stage biotechnology company dedicated to enabling the widespread application of human cells as medicine. The Company is developing a pipeline of proprietary product candidates intended to address cancer, cardiac diseases and infertility. ViaCell's portfolio of proprietary technologies include Selective Amplification technology and the USSC. The Company's lead stem cell therapy product candidate, a cord blood-derived stem cell therapeutic, CB001, is currently in a Phase I clinical trial. ViaCell offers expecting families the option of preserving their baby's cord blood stem cells through its Viacord business.
|
| |
Additional Photographs & Reprint Permissions |
Archived MarketSite Events |
Summary Quote
Reprints
|
